AUROBINDO PHARMA LTD. - 524804 - Outcome Of Board Meeting
Board has approved the following in its meeting held today, 12 August 2023: Has reinitiated to explore restructuring of Eugia Pharma Specialities Limited and Has accepted the resignation of Dr.M.Sivakumaran as Whole-time Director and Director of the Company w.e.f. August 24, 2023 AUROBINDO PHARMA LTD. - 524804 - Board Meeting Outcome for Outcome Of Board Meeting - Quarterly Results
The Board of Directors of the Company at its meeting held today, August 12, 2023, has inter alia, considered and approved the standalone and consolidated Unaudited Financial Results of the Company for the first quarter ended June 30, 2023, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors of the Company. The Board meeting commenced at 3.30 p.m. and concluded at 5.40 p.m. AUROBINDO PHARMA LTD. - 524804 - Board Meeting Outcome for Outcome Of Board Meeting - Quarterly Results
The Board of Directors of the Company at its meeting held today, August 12, 2023, has inter alia, considered and approved the standalone and consolidated Unaudited Financial Results of the Company for the first quarter ended June 30, 2023, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors of the Company. The Board meeting commenced at 3.30 p.m. and concluded at 5.40 p.m. AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificates.
Aurobindo Pharma shares hit 52-week high on US FDA approval for drug to treat infection
The company's board of directors will meet on August 12, 2023, to consider and approve the standalone and consolidated unaudited financial results of the company for the first quarter ended June 30, 2023. AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We enclose a copy of Press Release on receipt of USFDA Approval for Vancomycin Hydrochloride for injection AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Call to be held on August 14, 2023 at 8:30 AM (IST) on Unaudited Financial Results of the Company for the first quarter ended June 30, 2023. AUROBINDO PHARMA LTD. - 524804 - Completion Of US FDA Inspection At Our Unit VII
Completion of USFDA inspection or our unit VII. Inspection closed with zero observation and a classification of No Action Indicated (NAI). AUROBINDO PHARMA LTD. - 524804 - Board Meeting Intimation for Intimation Of Board Meeting
AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve We hereby inform pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a Meeting of the Board of Directors of the Company will be held on Saturday, August 12, 2023, to consider and approve inter alia, the Standalone & Consolidated Unaudited Financial Results of the Company for the first quarter ended June 30, 2023. Further to our letter dated June 28, 2023, informing the closure of Trading Window of the Company from July 1, 2023, until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the first quarter ended June 30, 2023, we inform you that the Trading Window will remain closed up to August 14, 2023, and shall be re-opened on August 15, 2023. AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached the notice published in the newspapers.